E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz

NEI Podcast

内容由Neuroscience Education Institute提供。所有播客内容（包括剧集、图形和播客描述）均由 Neuroscience Education Institute 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

3M ago 51:31

MP3•单集首页

What are the main reasons MAOIs are underutilized in psychiatric practice despite their proven efficacy for certain conditions? What are the key dietary restrictions patients must follow when taking MAOIs? What are the critical drug-drug interactions clinicians must be aware of when prescribing MAOIs? What clinical pearls or tips would you give to clinicians looking to become more comfortable using these agents?

Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on underutilized psychotropic drugs.

Today, Dr. Andy Cutler interviews Dr. Thomas Schwartz and Dr. Stephen Stahl about factors that have led to the underutilization of MAOIs in psychiatry.

Let’s listen to Part 2 of our theme: Underutilized Psychiatric Drugs.

Subscribe to the NEI Podcast, so that you don’t miss another episode!

Resources

Email roundtable@maoiexperts.topicbox.com for guidance on prescribing MAO inhibitors

The Prescriber's Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression

Practical Guide for Prescribing MAOIs: Debunking Myths and Removing Barriers

236集单集